The applicants' overall objective is to elucidate the role of T cells in the pathogenesis of RA and to identify new molecular approaches for the treatment of the disease. Significant evidence has been accumulated suggesting an important role for T lymphocytes in the pathogenesis of RA. The hypothesis to be tested in this research grant application is that T cells infiltrating the synovial membrane or extravasating into the synovial fluid are the result of clonal expansion of T lymphocytes undergoing activation and proliferation in response to a yet unknown set of (auto) antigens.
The specific aims of this proposal are: (1) To determine whether fresh (not expanded in culture) mononuclear cells infiltrating the synovial membrane or extravasating into the synovial fluid of patients with RA, contain substantial proportions of monoclonal T cells. To identify the V, D, and J gene segments employed by the alpha/beta or gamma/ delta T-cell antigen receptors (TCR) of these T cells, by amplifying the alpha-, beta-, gamma-, and delta-chain TCR cDNAs by the polymerase chain reaction (PCR), followed by cloning and sequencing; (2) To develop alpha/beta TCR+ or gamma/delta TCR+ T-cell clones from T cells infiltrating the synovial membrane or extravasating into the synovial fluid of patients with RA that are specific either for Mycobacterium tuberculosis antigens or type II collagen. To characterize these T cell clones and determine their reactivity to recombinant 65 kD M. tuberculosis antigen; (3) To identify the gene segments employed by the alpha/beta or gamma/delta TCR of these antigen-specific T cell clones, using amplification by PCR of the TCR cDNAs, followed by cloning and sequencing. To compare the sequences of the alpha/beta or gamma/delta TCR of these antigen-specific T cell clones to those of fresh T cells infiltrating the synovial membrane or extravasating into synovial fluid, in order to determine whether clonal populations of these infiltrating or extravasating cells have the same antigenic specificities with those of antigen-specific T cell clones; (4) in the event that the molecular analysis reveals that particular alpha/beta or gamma/delta TCR gene segments are primarily used by T cells infiltrating the synovial membrane or extravasating into the synovial fluid the investigators will develop anti-TCR monoclonal antibodies (mabs) specific for these segments, and the investigators will characterize the T cells recognized by these monoclonals. It is anticipated that these antibodies will be useful for treatment in vivo of patients with RA. These studies they hope will significantly improve our understanding of RA and will permit the development of new molecular approaches for the treatment of the disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR041003-02
Application #
3161440
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1991-09-01
Project End
1992-12-31
Budget Start
1992-09-01
Budget End
1992-12-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Sakkas, L I; Scanzello, C; Johanson, N et al. (1998) T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol 5:430-7
Sakkas, L I; Johanson, N A; Scanzello, C R et al. (1998) Interleukin-12 is expressed by infiltrating macrophages and synovial lining cells in rheumatoid arthritis and osteoarthritis. Cell Immunol 188:105-10
Lin, W L; Kuzmak, J; Pappas, J et al. (1998) Amplification of T-cell receptor alpha- and beta-chain transcripts from mouse spleen lymphocytes by the nonpalindromic adaptor-polymerase chain reaction. Hematopathol Mol Hematol 11:73-88
Mathioudakis, G; Good, R A; Chernajovsky, Y et al. (1996) Selective gamma-chain T-cell receptor gene rearrangements in a patient with Omenn's syndrome: absence of V-II subgroup (V gamma 9) transcripts. Clin Diagn Lab Immunol 3:616-9
Mitropoulos, D; Kooi, S; Rodriguez-Villanueva, J et al. (1994) Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma. Clin Exp Immunol 97:321-7
Sakkas, L I; Chen, P F; Platsoucas, C D (1994) T-cell antigen receptors in rheumatoid arthritis. Immunol Res 13:117-38
Kooi, S; Freedman, R S; Rodriguez-Villanueva, J et al. (1993) Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells. Lymphokine Cytokine Res 12:429-37
Fox, F E; Oleszak, E L; Chen, P F et al. (1992) Human hybridoma-derived suppressor factor 160 and transforming growth factor-beta are different molecules. Lymphokine Cytokine Res 11:307-15
Nanno, M; Seki, H; Ioannides, C G et al. (1992) Disulfide-linked and non-disulfide-linked gamma/delta T-cell antigen receptors: differential expression on T-cell lines and clones derived from normal donors and patients with primary immunodeficiency disorders. Anticancer Res 12:1069-78